Cargando…

Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

Detalles Bibliográficos
Autores principales: Hawarden, Amy, Russell, Bryn, Gee, Mary Ellen, Kayali, Fatima, Clamp, Andrew, Crosbie, Emma Jayne, Edmondson, Richard John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152121/
https://www.ncbi.nlm.nih.gov/pubmed/34039290
http://dx.doi.org/10.1186/s12885-021-08369-4
_version_ 1783698539531993088
author Hawarden, Amy
Russell, Bryn
Gee, Mary Ellen
Kayali, Fatima
Clamp, Andrew
Crosbie, Emma Jayne
Edmondson, Richard John
author_facet Hawarden, Amy
Russell, Bryn
Gee, Mary Ellen
Kayali, Fatima
Clamp, Andrew
Crosbie, Emma Jayne
Edmondson, Richard John
author_sort Hawarden, Amy
collection PubMed
description
format Online
Article
Text
id pubmed-8152121
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81521212021-05-26 Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study Hawarden, Amy Russell, Bryn Gee, Mary Ellen Kayali, Fatima Clamp, Andrew Crosbie, Emma Jayne Edmondson, Richard John BMC Cancer Correction BioMed Central 2021-05-26 /pmc/articles/PMC8152121/ /pubmed/34039290 http://dx.doi.org/10.1186/s12885-021-08369-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Hawarden, Amy
Russell, Bryn
Gee, Mary Ellen
Kayali, Fatima
Clamp, Andrew
Crosbie, Emma Jayne
Edmondson, Richard John
Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
title Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
title_full Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
title_fullStr Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
title_full_unstemmed Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
title_short Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
title_sort correction to: factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152121/
https://www.ncbi.nlm.nih.gov/pubmed/34039290
http://dx.doi.org/10.1186/s12885-021-08369-4
work_keys_str_mv AT hawardenamy correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy
AT russellbryn correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy
AT geemaryellen correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy
AT kayalifatima correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy
AT clampandrew correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy
AT crosbieemmajayne correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy
AT edmondsonrichardjohn correctiontofactorsdeterminingultrashorttermsurvivalandthecommencementofactivetreatmentinhighgradeserousovariancanceracasecomparisonstudy